transfer, or validation. It ensures data integrity and regulatory compliance through systematic trend analysis and scientific justification.

2. Scope

This SOP applies to all stability studies, in-process analysis, method development, and validation experiments where data trends are routinely evaluated in the Analytical Method Development (AMD) laboratory.

3. Responsibilities

• Analyst: Identifies potential OOT results and initiates preliminary documentation.
• AMD Scientist: Performs trend analysis and conducts detailed investigations where applicable.
• QA Personnel: Reviews investigation report and ensures closure with proper justification or CAPA implementation.

4. Accountability

The Head of AMD department is accountable for ensuring all OOT results are addressed promptly with appropriate investigations and regulatory documentation, aligned with ICH and FDA guidelines.

5. Procedure

5.1 Identification of Out of Trend Results

1. Collect historical data sets for assay, dissolution, content uniformity, and degradation products.
2. Graphically or statistically evaluate trends across batches and time points (e.g., using control charts).
3. Flag results that deviate from historical pattern but are still within specification as potential OOT.

5.2 Initial Assessment

1. Verify instrument calibration and system suitability data for the analytical run.
2. Review chromatograms or spectra for anomalies (baseline noise, tailing, overlapping peaks).
3. Ensure sample preparation logs are checked for accuracy and completeness.

5.3 OOT Investigation Phases

5.3.1 Phase I – Laboratory Investigation

1. Re-integrate chromatograms (if applicable) with QA oversight.
2. Repeat analysis using the same solution if stability permits.
3. Analyze freshly prepared sample and standard solutions, and compare data.
4. If results fall in trend upon re-analysis and justification is valid, conclude investigation with scientific reasoning.

5.3.2 Phase II – Extended Investigation

1. Initiate detailed root cause analysis if the Phase I investigation is inconclusive.
2. Assess analyst technique, method ruggedness, equipment logs, and recent maintenance.
3. Initiate deviation or CAPA if procedural lapses or equipment issues are identified.

5.4 Documentation

1. Record all observations in the OOT Investigation Report Template (Annexure-1).
2. Include:
   • Batch/product details
   • Test parameter and method reference
   • Date of analysis and instrument ID
   • Results with historical trend graph
   • Outcome and conclusion

5.5 Decision Making and Reporting

1. If confirmed OOT result is scientifically justified, document rationale in final report.
2. If root cause is procedural or analytical, implement corrective measures and re-train staff as needed.
3. Escalate to QA if product quality, batch disposition, or regulatory filing is affected.

5.6 Preventive Actions

1. Conduct quarterly review of trending data to identify patterns early.
2. Incorporate OOT trends into method robustness evaluations.
3. Update SOPs, training modules, or methods if recurring OOT observations are noted.

6. Abbreviations

• OOT: Out of Trend
• CAPA: Corrective and Preventive Action
• QA: Quality Assurance
• AMD: Analytical Method Development
• RCA: Root Cause Analysis

7. Documents

1. OOT Investigation Report Template – Annexure-1
2. OOT Statistical Analysis Form – Annexure-2
3. Corrective Action Summary Sheet – Annexure-3

8. References

• ICH Q10 – Pharmaceutical Quality System
• FDA Guidance for Industry – Investigating Out-of-Specification Test Results (2006)
• WHO Technical Report Series No. 996, Annex 7

9. SOP Version

Version: 2.0

10. Approval Section

	Prepared By	Checked By	Approved By
Signature
Date
Name	Radhika Mehta	Dr. Neeraj Kulkarni	Dr. Harshita Goyal
Designation	Senior Analyst	QA Reviewer	Head – AMD
Department	Analytical Method Development	Quality Assurance	Analytical Method Development

11. Annexures

Annexure-1: OOT Investigation Report Template

Includes product, test parameter, method version, analyst name, instrument used, result values, previous trend data, reason for deviation, conclusion.

Annexure-2: OOT Statistical Analysis Form

Test	Date	Result	Mean	Standard Deviation	Z-Score
Assay	25-May-2025	92.4%	98.2%	3.1	-1.87

Annexure-3: Corrective Action Summary Sheet

Details CAPA assigned, due dates, responsible person, effectiveness check status.

Revision History:

Revision Date	Revision No.	Details	Reason	Approved By
01/06/2025	2.0	Revised to add preventive actions and annexures	Annual Review	Dr. Harshita Goyal
14/05/2022	1.0	Initial release	New SOP	QA Head